Please use this identifier to cite or link to this item:
|Title:||Effect of nitric oxide releasing paracetamol and flurbiprofen on cytokine production in human blood||Authors:||Marshall, M.
TNF-α (tumour necrosis factor-α)
|Issue Date:||12-Jan-2004||Citation:||Marshall, M., Moore, P.K. (2004-01-12). Effect of nitric oxide releasing paracetamol and flurbiprofen on cytokine production in human blood. European Journal of Pharmacology 483 (2-3) : 317-322. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ejphar.2003.10.041||Abstract:||Exposure of anti-coagulated human blood to Escherichia coli lipopolysaccharide (50 ng/ml) resulted in the time-dependent (maximum at 5 h) biosynthesis of interleukin-1β and tumour necrosis factor-α (TNF-α). Preincubation with nitroparacetamol or nitroflurbiprofen (but not paracetamol or flurbiprofen) caused dose-related inhibition of the formation of interleukin 1β (IC50s, 44.5 and 362 μM, n=12) and tumour necrosis factor-α (IC50s, 9.0 and 0.0009 μM, n=12). The inhibitory effect of nitroparacetamol was completely reversed by (2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide; 2-(4-carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-1H-imidazol-1-yloxy-3-oxide potassium (carboxy-PTIO, 100 μM; NO scavenging agent). Neither the nuclear factor-κB transduction inhibitor, pyrrolidinedithiocarbamate (10-1000 μM) nor the nitric oxide donor, 1-hydroxy-2-oxo-3-(3-aminopropyl)-3- isopropyl-1-triazene (NOC-5, 10-1000 μM), affected cytokine formation in these experiments. © 2003 Elsevier B.V. All rights reserved.||Source Title:||European Journal of Pharmacology||URI:||http://scholarbank.nus.edu.sg/handle/10635/108061||ISSN:||00142999||DOI:||10.1016/j.ejphar.2003.10.041|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 20, 2020
WEB OF SCIENCETM
checked on Jul 10, 2019
checked on Jan 18, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.